Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Adiponectin: action, regulation and association to insulin sensitivity.

Lihn AS, Pedersen SB, Richelsen B.

Obes Rev. 2005 Feb;6(1):13-21. Review.

PMID:
15655035
[PubMed - indexed for MEDLINE]
2.

The role of the novel adipocyte-derived hormone adiponectin in human disease.

Díez JJ, Iglesias P.

Eur J Endocrinol. 2003 Mar;148(3):293-300. Review.

PMID:
12611609
[PubMed - indexed for MEDLINE]
Free Article
3.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

PMID:
16613757
[PubMed - indexed for MEDLINE]
4.

Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying actions of the thiazolidinediones.

Smith SA.

Biochimie. 2003 Dec;85(12):1219-30. Review.

PMID:
14739074
[PubMed - indexed for MEDLINE]
5.

Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.

Mojiminiyi OA, Abdella NA, Al Arouj M, Ben Nakhi A.

Int J Obes (Lond). 2007 Feb;31(2):213-20. Epub 2006 Jun 6.

PMID:
16755284
[PubMed - indexed for MEDLINE]
6.

Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.

Sepilian V, Nagamani M.

J Soc Gynecol Investig. 2005 Feb;12(2):129-34.

PMID:
15695109
[PubMed - indexed for MEDLINE]
7.

Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

Osei K, Gaillard T, Schuster D.

Obes Res. 2005 Jan;13(1):179-85.

PMID:
15761178
[PubMed - indexed for MEDLINE]
8.

Adiponectin--a key adipokine in the metabolic syndrome.

Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB.

Diabetes Obes Metab. 2006 May;8(3):264-80. Review.

PMID:
16634986
[PubMed - indexed for MEDLINE]
9.

Adiponectin, the missing link in insulin resistance and obesity.

Gil-Campos M, Cañete RR, Gil A.

Clin Nutr. 2004 Oct;23(5):963-74. Review.

PMID:
15380884
[PubMed - indexed for MEDLINE]
10.

[Adiponectin: a new link between obesity, insulin resistance and cardiovascular disease].

Palomer X, Pérez A, Blanco-Vaca F.

Med Clin (Barc). 2005 Mar 19;124(10):388-95. Spanish.

PMID:
15766512
[PubMed - indexed for MEDLINE]
11.
12.

Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE.

J Biol Chem. 2004 Mar 26;279(13):12152-62. Epub 2003 Dec 29.

PMID:
14699128
[PubMed - indexed for MEDLINE]
Free Article
13.

Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women.

Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeiffer AF, Schernthaner G.

Int J Obes (Lond). 2005 Jul;29(7):766-71.

PMID:
15917853
[PubMed - indexed for MEDLINE]
14.

Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance.

Li M, Kim DH, Tsenovoy PL, Peterson SJ, Rezzani R, Rodella LF, Aronow WS, Ikehara S, Abraham NG.

Diabetes. 2008 Jun;57(6):1526-35. doi: 10.2337/db07-1764. Epub 2008 Mar 28.

PMID:
18375438
[PubMed - indexed for MEDLINE]
Free Article
15.

Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.

Patel DA, Srinivasan SR, Xu JH, Chen W, Berenson GS.

Metabolism. 2006 Nov;55(11):1551-7.

PMID:
17046560
[PubMed - indexed for MEDLINE]
16.

The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo.

Li L, Yang G, Shi S, Yang M, Liu H, Boden G.

Cytokine. 2009 Jan;45(1):12-9. doi: 10.1016/j.cyto.2008.10.006. Epub 2008 Nov 20.

PMID:
19026557
[PubMed - indexed for MEDLINE]
17.

The metabolic syndrome: metabolic changes with vascular consequences.

Wassink AM, Olijhoek JK, Visseren FL.

Eur J Clin Invest. 2007 Jan;37(1):8-17.

PMID:
17181562
[PubMed - indexed for MEDLINE]
18.

[Adiponectin--adipocytokine with a broad clinical spectrum].

Szopa M, Malczewska-Malec M, Wybrańska I, Kieć-Wilk B, Bodzioch M, Trzos M, Dembińska-Kieć A.

Przegl Lek. 2004;61(2):109-14. Review. Polish.

PMID:
15230153
[PubMed - indexed for MEDLINE]
19.

Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.

Lewandowski KC, Szosland K, O'Callaghan C, Tan BK, Randeva HS, Lewinski A.

Mol Genet Metab. 2005 May;85(1):61-9. Epub 2005 Feb 12.

PMID:
15862282
[PubMed - indexed for MEDLINE]
20.

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways.

Kubota N, Terauchi Y, Kubota T, Kumagai H, Itoh S, Satoh H, Yano W, Ogata H, Tokuyama K, Takamoto I, Mineyama T, Ishikawa M, Moroi M, Sugi K, Yamauchi T, Ueki K, Tobe K, Noda T, Nagai R, Kadowaki T.

J Biol Chem. 2006 Mar 31;281(13):8748-55. Epub 2006 Jan 23.

PMID:
16431926
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk